Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer
Author:
Publisher
Wiley
Subject
Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.molonc.2011.11.009/fullpdf
Reference83 articles.
1. Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay;Arcila;Clin. Cancer Res.,2011
2. Tumor regression and pharmacodynamic biomarker validation in non-small cell lung cancer patients treated with the ErbB/VEGFR inhibitor BMS-690514;Bahleda;J. Clin. Oncol.,2009
3. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3;Baselga;Nat. Rev. Cancer,2009
4. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib;Bean;Proc. Natl. Acad. Sci. U. S. A.,2007
5. PF-00299804 (PF299) patient reported outcomes and efficacy in adenocarcinoma and non-adeno non-small cell lung cancer: a phase II trial in advanced NSCLC after failure of chemotherapy and erlotinib;Campbell;J. Clin. Oncol.,2010
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development and advanced applications of hepatobiliary tumor organoid models in drug response prediction;Asia-Pacific Journal of Oncology;2024-08-25
2. Clinical perspectives of rare ovarian tumors: clear cell ovarian cancer;Japanese Journal of Clinical Oncology;2023-06-07
3. Epigenetic Therapy as a Potential Approach for Targeting Oxidative Stress–Induced Non-small-Cell Lung Cancer;Handbook of Oxidative Stress in Cancer: Mechanistic Aspects;2022
4. Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis;Journal of Medicinal Chemistry;2021-11-04
5. Epigenetic Therapy as a Potential Approach for Targeting Oxidative Stress–Induced Non-Small-Cell Lung Cancer;Handbook of Oxidative Stress in Cancer: Mechanistic Aspects;2021-10-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3